4.7 Article

Serum YKL-40 as a marker for cervical adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

C-reactive protein is a prognostic parameter in patients with cervical cancer

Stephan Polterauer et al.

GYNECOLOGIC ONCOLOGY (2007)

Review Oncology

Serum YKL-40, a new prognostic biomarker in cancer patients?

JS Johansen et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)

Article Immunology

Circulating YKL-40 levels during human endotoxaemia

JS Johansen et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)

Article Oncology

Early detection and prognosis of ovarian cancer using serum YKL-40

J Dupont et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

Article Obstetrics & Gynecology

Serum CA 125 is an independent prognostic factor in cervical adenocarcinoma

DP Bender et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)

Article Obstetrics & Gynecology

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer

H Dehn et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2003)

Article Biochemistry & Molecular Biology

YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes

F De Ceuninck et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)